Literature DB >> 21547884

Minimal inspiratory flow from dry powder inhalers according to a biphasic model of pressure vs. flow relationship.

Kazuo Kanabuchi1, Tetsuri Kondo, Toshimori Tanigaki, Sakurako Tajiri, Naoki Hayama, Yoko Takahari, Kayoko Iwao.   

Abstract

Inhalation therapy using the dry powder inhaler (DPI) is now the first choice for obstructive pulmonary diseases. We previously measured relationships between inspiratory pressure (PI) and flow rate of almost all of the DPIs available in Japan, and described an importance of inspiratory efforts. In the present study, we further analyzed the data obtained in the previous study. Although there were linear relationships between PI and flow2, the slope became steeper when PI was less than a certain value (critical PI, existed between 15-20 cmH2O). When PI was less than critical PI, linear rather than parabolic regression between PI and flow yielded better fits (r > 0.90, p < 0.001). Inspiratory flows at the critical PI were 53.9 (Diskus), 65.8 (Diskhaler), 45.9 (Turbuhaler for Pulmincort), 48.6 (Turbuhaler for Symbicort) and 38.0 l/min (Twisthaler). These findings suggested that flow through the DPI becomes laminar rather than turbulent flow in the range below critical PIs. We suggest that patients should inhale from the DPIs with inspiratory pressure higher than critical PI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547884

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  3 in total

1.  Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

Authors:  Hiroko Otake; Tomoyuki Okuda; Daiki Hira; Haruyoshi Kojima; Yasuhiro Shimada; Hirozazu Okamoto
Journal:  Pharm Res       Date:  2015-12-07       Impact factor: 4.200

2.  Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions.

Authors:  Giorgio Walter Canonica; Jan Arp; Johan René Keegstra; Henry Chrystyn
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-09-09       Impact factor: 2.849

3.  Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device.

Authors:  Mark R Elkins; Sandra D Anderson; Clare P Perry; Evangelia Daviskas; Brett Charlton
Journal:  Open Respir Med J       Date:  2014-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.